Improving T Cell Therapies via Next Generation Technologies
The pipeline of adoptive T-cell therapies and other cell based immuno-oncology programs continues to expand with a number of modifications and improvements to the first generation programs. These plat...
17 Okt 201949min
Monetizing Science: Turning an Asset into Value through IPOs
This panel moderated by Dr Andrew Baum, Citi and recorded at the 5th annual IO360° Summit discusses the preparation of an IPO, straight licensing with the transition to a public company and decision m...
16 Okt 201936min
IDO Changes the T-cell Balance in the Tumor Microenvironment
In this talk recorded at the 5th annual IO360° Summit, Dr Charles Link Jr, Newlink Genetics, addresses how IDO changes the T-cell balance in the tumor microenvironment. This talk addresses how: IDO c...
16 Okt 201917min
Insights from Deal Trends: Betting on Tumor Immunology
In this podcast from the 2019 Immuno-Oncology 360° conference, Cello Health BioConsulting's EVP, Oncology Practice Head, Dr Jeff Bockman discusses deal-making and investments in the I-O space to see w...
29 Aug 201922min
Living with Alzheimer’s from a Young Patient's Perspective
Pharma Talk Radio producer, Valerie Bowling recently spoke with a young Alzheimer's patient, Jeff Borghoff. Jeff was officially diagnosed with Alzheimers in 2016 and is an active and patiionate patien...
23 Aug 201919min
Organizational and Digital Restructuring to Scale Mobile Clinical Trials
In this podcast from the 2018 Mobile in Clinical Trials conference, Mohammad Ali, Global Head Digital Trials- Global Clinical Operations, Boehringer-Ingelhiem and Joe Dustin, Principal, Mobile Health,...
23 Aug 201922min
How to Align the Promise of Technology with the Patient Voice
In this podcast from the 2018 Mobile in Clinical Trials conference, patient advocate, Cindy Geoghegan sat down with Dr Daniel Karlin, CEO, Healthmode and Deanna Lennon, Director of Business Developmen...
22 Aug 201935min
The Role of Digital Biomarkers and the Impact on Drug Delivery
In this podcast from the 2018 PODD: Partnership Opportunities in Drug Delivery conference, Dr Christopher Kovalchick, Chief Engineer, Drug Delivery & Devices R&D Innovation at Eli Lilly and Company pr...
22 Aug 201918min
